A potential therapeutic target for the treatment of psoriasis has been identified. Psoriasis is a chronic inflammatory disease of the skin that affects up to a 2% of the population and which has still no cure. The study shows that the TREX2 gene has a relevant role in the inflammatory response that develops during the illness.